promising bcma-targeting car-t cells for relapsed myeloma
Published 3 years ago • 65 plays • Length 4:51Download video MP4
Download video MP3
Similar videos
-
0:53
incorporating bcma-targeted car-t therapy in the frontline treatment of multiple myeloma
-
5:12
clinical activity seen with anti-bcma car t-cell therapy for heavily pre-treated multiple myeloma
-
0:36
promise of gprc5d-targeted car-t therapies in multiple myeloma
-
1:02
bcma-specific car-t cells for r/r multiple myeloma
-
2:27
bms-986393, a novel anti-gprc5d car-t cell therapy, in multiple myeloma
-
3:35
the future of anti-bcma car t-cell therapy in myeloma
-
1:53
phe885, a t-charge manufactured bcma-directed car-t therapy in r/r myeloma
-
4:04
overcoming challenges in car t-cell therapy for multiple myeloma
-
49:59
car t-cell therapy: multiple myeloma
-
4:04
the future of myeloma treatment and the possibility of cure
-
23:54
car-t cell therapy for multiple myeloma - michaela liedtke, md | mcrt webcast apr 24, 2021
-
1:21
sequencing of bcma-directed therapies for multiple myeloma
-
1:29
sequencing bcma-targeted therapies in myeloma
-
2:57
strategies to optimize car-t therapy in myeloma: bringing car-t into earlier lines
-
0:58
novel car-t constructs emerging in multiple myeloma for patients who experience loss of bcma
-
0:59
phase i study of cart-ddbcma in r/r multiple myeloma
-
2:35
latest advances in car-t for multiple myeloma: cilta-cel & new car-t platforms
-
1:34
bcma-targeting car-t: lessons moving forward
-
9:58
the management & optimization of car t-cell therapy in myeloma
-
4:14
car t-cell therapy for refractory multiple myeloma
-
5:00
meta-analysis: anti-bcma car-t in r/r multiple myeloma